pramipexole

Published research on pramipexole.

CognitionNov 8, 2026

Pembrolizumab Plus Lenvatinib Linked to Reversible Confusion and Akathisia

A 2026 case report describes a 69-year-old woman with anxiety and depression who became confused, slowed and severely restless on pembrolizumab plus lenvatinib and sedating psychiatric drugs…

Read article →

DrugsJan 5, 2024

Effects of Pramipexole on Reward Learning: Possible Depression Treatment? (2023 Study)

In a significant stride toward understanding and treating depression, a 2023 study meticulously investigates the effects of pramipexole, a dopamine D2-like agonist, on reward learning. By ex…

Read article →

DrugsFeb 7, 2016

Mirapex (Pramipexole) For Depression: An Effective Antidepressant?

Mirapex (Pramipexole) is a drug that is approved by the FDA for the treatment of Parkinson’s disease and RLS (restless leg syndrome). Classified as a dopamine receptor agonist, pramipexole e…

Read article →

DrugsFeb 4, 2016

Mirapex (Pramipexole) Side Effects & Adverse Reactions (List)

Mirapex (Pramipexole) is a medication that was approved by the FDA in 1997 for the treatment of idiopathic (early-stage and advanced) Parkinson’s disease. Analysis of the drug’s pharmacodyna…

Read article →